Background TS-1 can be an mouth anticancer medication containing a 5-fluorouracil derivative (Tegafur) that’s trusted in Japan for the treating cancer, gastrointestinal tumors especially. A biomarker applicant from SELDI profiling was determined using a mix of cation exchange spin column purification, SDS-PAGE, enzymatic LC-MS/MS and digestion. Outcomes After administration of TS-1, a substantial reduction in… Continue reading Background TS-1 can be an mouth anticancer medication containing a 5-fluorouracil